常规抗心衰药物联合β受体阻滞剂对心力衰竭治疗效果分析.docVIP

常规抗心衰药物联合β受体阻滞剂对心力衰竭治疗效果分析 　　[摘要] 目的 研究β受体阻滞剂在临床治疗心力衰竭的过程中的应用价值。 方法 随机择取该院2014年10月―2015年10月收治的120例心力衰竭患者随机分为对照组、观察组，所有患者接受常规抗心衰药治疗，观察组同时加用β受体阻滞剂进行治疗，记录患者治疗后血压、心率、心功能状态以及药物不良反应情况，分析其临床效果。 结果 观察组舒张压、收缩压、心率等指标明显低于对照组，心功能较对照组明显升高，差异有统计学意义，P0.05。且观察组显效33例，有效25例，2例患者治疗无效，有效率为96.7%，对照组显效21例，有效30例，9例患者治疗无效，有效率为85.0%，明显低于观察组疗效（96.7%），P0.05。 结论 采用β受体阻滞剂与常规抗心衰药联合治疗心力衰竭可以显著改善患者临床症状与心功能情况，较常规抗心衰治疗效果更明显，疗效确切，副作用少，值得推广应用。 　　[Abstract] Objective To research the application value of beta blocker in clinical treatment of heart failure. Methods 120 cases of patients with heart failure treated in our hospital from October 2014 to October 2015 were selected and randomly divided into the control group and the observation group， all patients were treated with routine cardiotonic agents， at the same time， the observation group were treated with additional beta blocker， the blood pressure， heart rate， state of heart function and adverse reactions of drugs after treatment of the patients were recorded， and the clinical effect was analyzed. Results The indicators such as diastolic pressure， systolic pressure and heart rate in the observation group were obviously lower than those in the control group， the heart function in the observation group was obviously increased compared with that in the control group， and the difference was obvious P0.05， in the observation group， 33 cases were markedly effective， 25 cases were effective， 2 cases were ineffective， and the effective rate was 96.7%， in the control group， 21 cases were markedly effective， 30 cases were effective， 9 cases were ineffective， and the effective rate was 85.0%， the curative effect in the control group was obviously lower than that in the observation group， P0.05. Conclusion The combined treatment of beta blocker and routine cardiotonic agents for heart failure can obviously improve the patient’s clinical symptom and heart function， and the treatment effect of it is more obvious compared with that of routine cardiotonic agents